WO2008152224A2 - Valve cardiaque prothétique mécanique - Google Patents
Valve cardiaque prothétique mécanique Download PDFInfo
- Publication number
- WO2008152224A2 WO2008152224A2 PCT/FR2008/000621 FR2008000621W WO2008152224A2 WO 2008152224 A2 WO2008152224 A2 WO 2008152224A2 FR 2008000621 W FR2008000621 W FR 2008000621W WO 2008152224 A2 WO2008152224 A2 WO 2008152224A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- flap
- valve
- valve according
- flaps
- shutter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2403—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with pivoting rigid closure members
Definitions
- the present invention relates to a mechanical prosthetic heart valve.
- bioprostheses which are taken from the animal then chemically treated or constructed from biological tissues on the model of a natural valve
- bioprostheses offer biological performances that are the same as those of a natural heart valve because they respect the natural structure of the flow of blood through the heart cavities. the aorta.
- the patient may forget that he is wearing an artificial heart valve.
- the bioprostheses do not cause acoustic nuisance, which also helps to make the patient forget that he is carrying an artificial heart valve.
- These bioprostheses have a limited life because of their inevitable calcification over time, which requires a replacement after a period of about ten years on average. Once initiated, this calcification accelerates and destroys the valve with the consequent progressive degradation of valve function and its impact on the heart muscle. Calcification occurs more rapidly in young than in older subjects, limiting the scope of bioprosthetics to subjects over 65 years of age or to subjects whose life expectancy is less than the lifetime of the patient. bioprosthesis.
- This powerful biological phenomenon is the very one that governs the physiological process of healing the vessel's inner lining. It prevents leakage of blood outside the circulatory system. It is therefore essential to the maintenance of life and difficult to thwart.
- coagulation deposits can not only impede the mechanical function of the valve on the bloodstream, which puts the lives of patients at risk, but also migrate into the circulation
- thrombosis generates thrombosis and creates a chronic disease that is self-sustaining.
- Normalized Ratio at a level at least two and one-half times the physiological value (INR 2.5).
- Patients with a mechanical valve in the mitral position must maintain their blood coagulability at a rate at least three and a half times greater than the physiological value (INR 3.5).
- This difference in the "harmfulness" of mechanical prostheses between the aortic position and the mitral position is due to the fact that the velocity of the blood is lower through the mitral orifice than through the aortic orifice.
- the duration of filling of the heart through the mitral valve (typically of the order of 450 milliseconds to 70 cycles per minute) is indeed longer than the duration of the ejection of blood through the aorta (typically from the order of 300 milliseconds).
- the contact time of the blood with the prosthetic valve in the mitral position is therefore longer, which allows the coagulation processes to be completed.
- 6,395,024 discloses a mechanical prosthetic heart valve which comprises a ring provided with an inner peripheral surface centered about an axis and three flaps arranged near the inner peripheral surface of the ring. These three flaps are adapted to effect a pivoting movement between, on the one hand, a closed position preventing the blood from flowing through the valve and, on the other hand, an open position in which the flow of blood crosses the valve in an axial direction.
- the ring comprises, on the one hand, an edge, called downstream edge, connecting the inner peripheral surface to an outer peripheral surface and which is placed on the downstream side of the flow and, on the other hand, three slots or protuberances which are extend from this edge downstream, in the axial direction.
- Each flap comprises a central portion provided with two lateral flanges which each cooperate with means for rotating the flap respectively arranged on the inner surfaces of two consecutive crenellations.
- the space in which each flap side wing pivots is called the pivotal space.
- each window allows a satisfactory rinsing of the outer face of the lateral wings of the flaps by retrograde flow.
- this outer face can be swept by the flow of blood flowing from the ventricle to the aorta.
- the reflux of blood through these windows into the aortic sinuses when the valve is closed can ensure rinsing of the outer side of the lateral wings, preventing a volume of blood can be retained captive in the pivoting spaces of the shutter.
- the lower edge of the windows described above forms with the leading edge of the lateral wings of the flaps, when they are in open position, a second opening having a triangular shaped form.
- This second opening (called “cleft” in English terminology) is “dynamic” because the surface of the orifice thus formed increases gradually when the flap passes from the closed position to the open position. It allows the direct passage to the outside of the flaps of the blood conveyed by the anterograde flow and provides an additional scan of the leading edge and the outer face of the wings of the flaps.
- the Applicant has found from implantations performed on the animal that the effect of this additional arrangement on blood flow was not the same in the mitral position and the aortic position. Indeed, the aforementioned arrangement has been effective on a large number of animals implanted with the valve in the mitral position and left for many months without anticoagulant protection, while it was otherwise animals on which the same valve has been implanted in the aortic position.
- the blood under low pressure can flow through the second openings ("clefts") from the inside of the valve to the the outside in the flap pivoting spaces, during ventricular filling, and flush critical pivoting spaces.
- the blood pressure generated by the heart, during ventricular ejection, through the aortic implanted valve is ten times higher than the blood pressure exerted through the valve implanted in the mitral position.
- the rinsing effect in the aortic position creates, at each heartbeat, powerful lateral "jets" which exceed the desired rinsing goal and reach traumatic values for blood cells.
- the traumatic threshold recognized by the state of the art in the field is around a force of 150 dynes / cm 2 for blood platelets and 1000 dynes / cm 2 for red blood cells. Beyond these values, the blood elements are sheared, the platelets release their coagulants, which can cause coagulation complications.
- the hinge mechanism of the flaps imposes an unfavorable geometry to a good structure of the blood flow in the pivoting spaces. It generates shears and micro turbulence in the immediate vicinity of surfaces relatively poorly scanned by the blood stream.
- the amplitude of this phenomenon is related to the number of articulation zones of the valve. It is therefore larger for a heart valve to three flaps that have six pivoting spaces for a two-part heart valve that has only four.
- the present invention aims to remedy at least one of the disadvantages of the prior art by proposing a mechanical prosthetic heart valve, characterized in that it comprises:
- annular support having an inner peripheral surface centered around a longitudinal axis X, at least two movable flaps which are arranged in an articulated manner on the inner peripheral surface of the support so as to be able to perform a rotational movement around each other; a flap rotation axis perpendicular to the longitudinal axis, to pass from an open position of the valve, in which the open flaps delimit between them a main orifice centered on the longitudinal axis and through which the blood flows axially, at a closed position of the valve, in which the closed flaps prevent the blood from flowing back through the main orifice, the annular support having an edge placed on the downstream side of the anterograde flow, called the downstream edge, and several extensions articular which extend axially from the downstream edge and whose number corresponds to that of the flaps, each flap having a central portion symmetrically framed by two lateral wings which are inclined relative to this central part, these two wings cooperating respectively, to allow rotation of the flap, with the inner surfaces of two articular
- the outer surface of the flaps is better swept by the flow of blood than before, in particular, in line with the lateral wings of the flaps.
- the invention makes it possible to considerably reduce the risk of blocking the shutters at the opening, which could occur by interposing a coagulation deposit between the outer surfaces of the lateral parts of the shutters and the internal surfaces facing the articular extensions. corresponding.
- this interposition by coagulation deposits can also be the source of embolism in the peripheral blood circulation.
- the invention thus makes it possible to eliminate or, at the very least, drastically reduce the use of anticoagulant drugs.
- the Applicant has been able to observe, thanks to the analysis of the microstructure of the blood flow at this point, when the flaps are in the open position, the presence downstream of the junction zone, close to the pivoting spaces, a micro-vortex current that recurs at each cycle.
- each lateral wing of each flap is connected to the central part of the shutter by a junction zone whose outer surface is convex and which, over at least part of its length including the portion of the downstream zone of the anterograde flow (trailing edge), has a radius of curvature large enough to prevent the formation of swirling flows at the neighborhood of this surface.
- the increase in the radius of curvature has the consequence of keeping the portion of the flap concerned by this modification of the radius of curvature in a flow zone subjected to a velocity gradient substantially similar to that to which the remainder of the flap is subjected. , further attenuating the distortions of the flow in this critical zone.
- the part of the flap concerned by this particular arrangement is, for example, that located from a distance of about 20% of the flap leading edge.
- Such a radius of curvature depends on the dimensions of the flap and is determined by the skilled person for each size of valve, so as to obtain the desired effect.
- the radius of curvature of the junction zone located on the downstream side of the flow is at least 2 mm for a valve intended to be implanted in the aortic position and at least 3 mm for a valve intended for to be implanted in a mitral position.
- each lateral wing of each of the flaps is connected to the central part of the shutter by a junction zone whose outer surface is convex and has the general shape of a cone portion whose apex is located towards the upstream of the antegrade flow.
- the radius of curvature between each lateral wing and the central part of the flap is not substantially modified in the immediate vicinity of the leading edge of the flap, but it is all the more modified. that one approaches the trailing edge of the shutter (edge of the shutter located on the downstream side of the flow).
- each lateral wing of each flap is connected to the central part of the flap by a junction zone whose outer surface is convex and has the general shape of a cylinder portion.
- the axis of rotation of each flap is virtual, located outside the flap, between the latter and the annular support, and extends in a direction taken by moving from one side wing of the flap to the opposite lateral wing.
- the flap rotation axis is located at a distance from the longitudinal axis X which is greater than 75% of the radius of the annular support.
- each of the articulation facets of a flap and the corresponding extension facet of the articular extension concerned of the annular support define between them, when the flap is in the closed position, a pivoting space of the flap, this space disappearing when the flap hinge facet comes, in the open position, bearing against the corresponding extension facet.
- the volume of the pivoting space is less than 2 / 10Oe of the volume displaced by the flap during its passage from the closed position to the open position.
- the outer surface of the central part of the flap has a generally convex general shape in a direction taken by moving from one side wing of the flap to the opposite side wing.
- each flap has an inner surface facing the main orifice of the valve and which has a generally substantially concave shape in a direction taken by moving from one side wing of the flap to the side wing opposite.
- the main orifice delimited by the inner surfaces of the flaps has, in projection in a plane perpendicular to the longitudinal axis of the annular support, a passage section offered to the flow which is equal to at least 75% of the internal surface delimited by the annular support in this same plane.
- each flap when the valve is in the open position, each flap defines, between its outer surface and the inner peripheral surface portion of the annular support which separates the two articular extensions with which the flap cooperates, a secondary orifice.
- each secondary orifice has a general crescent shape.
- the dimension of the secondary orifice, taken in a radial direction, in projection in a plane perpendicular to the longitudinal axis of the annular support is less than 20% of the internal radius of the annular support.
- each secondary orifice has, in a plane perpendicular to the longitudinal axis of the annular support, a passage section offered to the flow which is less than 7% of the internal surface delimited by the annular support in this same plane.
- the articular extensions are each without any through aperture.
- the annular support has on its inner peripheral surface, near the downstream edge and for each flap, two stops causing the immediate pivoting of the flap in its open position when the blood pressure is exerted on the inner face of the flap. shutter.
- the annular support has on its inner peripheral surface, for each flap, two support means for the flap in the closed position, said support means of each flap being arranged between the two articular extensions with which the lateral flanges of the flange respectively cooperate. shutter.
- each stop in projection in a plane perpendicular to the longitudinal axis of the annular support, each stop is angularly spaced from the nearest support means by a distance substantially corresponding to at least half the width of said support means, the width being measured, in the plane considered, in a tangential direction relative to the annular support.
- the stops are arranged between the flap support means.
- each flap comprises at its periphery, on the one hand, a leading edge which is disposed on the upstream side of the antegrade blood flow and cooperates with the inner surface of the annular support in the closed position of the flap and, on the other hand, a trailing edge disposed on the downstream side of the anterograde flow.
- each flap support means cooperates with a contact zone of the flap leading edge in a surface contact and not a linear contact when closing said flap.
- each flap support means has an upper end surface, a portion on the side opposite to the nearest joint extension has a radius of curvature large enough to cooperate with the transverse rectilinear contact area of the edge. flap attack following a surface contact and not linear.
- the trailing edge of each flap has a substantially triangular shape and, in the closed position of the valve, the trailing edges of the three flaps cooperate with one another to form a trihedron whose tip is directed towards the downstream.
- each flap has, in its central part, at the trailing edge, an area aligned along the axis of symmetry of the flap and which is substantially in the shape of a ski spatula at its free end downstream, the end substantially spatulated flap forming a tip which deviates from the extension of the inner surface of said flap at an angle substantially between 2 and 4 °.
- the three substantially spatulated ends of the flaps remain spaced apart from one another, in the closed position of the valve, by at least 50 microns and form between them a central interstice in the form of a star with three branches.
- each of the three branches extends over a distance corresponding to at least one third of the total length of the trailing edge of the flaps.
- each shutter on the one hand, in the closed position, forms with a plane perpendicular to the longitudinal axis (X) of the annular support a closure angle of between 30 ° and 50 ° and, on the other hand, in the open position, is substantially parallel to the direction of flow.
- the closing angle is between 40 ° and 50 ° for valves intended to be implanted in the mitral position.
- each flap has on its outer surface one or more zones provided with grooves which promote the orientation of the blood flow towards the lateral flaps of the flap.
- the annular support has on its outer peripheral surface, for the valves intended to be implanted in aortic position, a peripheral rib for fixing a suture ring, the rib being configured so that its general shape reproduce the profile of a substantially sinusoidal curve having a vertex arranged at the right of each joint extension and a hollow between two consecutive articular extensions.
- the invention also relates to a movable flap intended to be mounted on an annular support of a mechanical prosthetic heart valve, comprising at its periphery, on the one hand, a leading edge which is intended for be disposed on the upstream side of the anterograde blood flow and, on the other hand, a trailing edge which is intended to be disposed on the downstream side of this flow, the flap comprising a central portion symmetrically framed by two lateral wings which are inclined with respect to this central part, each lateral wing being connected to the central part by a junction zone whose outer surface is convex and which, on at least one part of its length including the trailing edge, has a radius of curvature large enough to avoid the separation of the flow and the formation of swirling flows in the vicinity of this junction surface.
- the radius of curvature of the junction zone to the right of the trailing edge is at least 2 mm for a valve intended to be implanted in the aortic position and at least 3 mm for a valve intended to be implanted. in mitral position.
- the outer surface of the junction zone has the general shape of a cone portion whose apex is located on the opposite side to the trailing edge of the flap.
- the outer surface of the junction zone has the general shape of a cylinder portion.
- the flap has an outer surface and an inner surface opposite to each other and each connecting the leading edge to the trailing edge.
- the outer surface of the central part of the flap has a generally convex general shape in a direction taken by moving from one side wing of the flap to the opposite side wing.
- the inner surface of the central portion of the flap has a generally substantially concave shape in a direction taken by moving from one side wing of the flap to the opposite side wing.
- the flap has on its outer surface one or more zones provided with grooves which promote the orientation of the blood flow towards the lateral wings.
- the flap has, in its central part, at the trailing edge, an area aligned along the axis of symmetry of the flap and which is substantially in the form of a ski spatula at its free end, the end substantially spatulate flap forming a tip which deviates from the extension of the inner surface of said flap at an angle substantially between 2 and 4 °.
- the flap is rigid.
- the flap is made from a biocompatible material and is optionally made of monolithic carbon, graphite with a pyrolytic carbon coating or in a synthetic polymer with wear resistance properties comparable to those pyrolytic carbon.
- FIG. 1 is a schematic perspective view of a valve according to the invention with the flaps arranged in the open position
- - Figure 2 is a schematic perspective view of the valve of Figure 1 with the shutters in the closed position
- Figure 3 is a partial schematic view showing the cooperation of a shutter in the open position with an articular extension according to the invention and respectively according to the prior art (dashed), seen from the outside of the valve;
- FIG. 4a is a partial schematic perspective view of the interior of the valve, showing the arrangement of a shutter in the open position housed between two articular extensions of the support;
- - Figure 4b is an enlarged partial schematic view of a support means cooperating with the leading edge of a flap;
- FIGS. 5 and 7 are schematic front views and perspective of the outer surface of a shutter according to the invention.
- FIGS. 6 and 8 are schematic front views and in perspective of the outer surface of a flap according to the prior art
- FIG. 9 is a view of a shutter according to the invention in cross section in a plane containing the axis of symmetry Z;
- - Figure 10 is a schematic top view of a valve according to the invention with the flaps in the closed position;
- - Figure 11 is a partial schematic view showing the arrangement of the lateral wings of two flaps in the open position relative to an articular extension 32 of the valve;
- FIG. 12 is a schematic top view of a valve according to the invention with the flaps in the open position
- FIGS. 13 and 14 are partial schematic views taken in the plane of the central portion of a flap according to the invention, respectively the leading edge and the trailing edge of one of the junction areas of said flap;
- - Figure 15 is a schematic sectional view of a longitudinal section of a shutter according to the invention;
- FIG. 16 is an enlarged partial schematic view of a pivoting space of a valve according to the invention.
- FIG. 17 is a partial schematic view showing the inclination of a shutter in the closed position of a valve according to the invention.
- - Figure 18 is a schematic representation of the flow of blood on the outer surface of a shutter according to the invention in the absence of grooves
- - Figure 19 is a schematic view showing the flow of blood on the outer surface of a shutter according to the invention in the presence of grooves
- FIG. 20 is a partial schematic view of a possible shape of grooves according to the invention.
- a mechanical prosthetic heart valve according to the invention comprises an annular support in the form of a ring 12 which defines inside it an internal passage 14 for the cyclic flow of blood under the action of cardiac contractions.
- the flow through the valve 10 in the open position thereof is referred to as antegrade current and its direction of flow is indicated by the arrow A in Figure 1.
- retrograde current the current flowing in the opposite direction when closing the valve.
- the central internal passage 14 for the flow of blood is delimited by the inner peripheral surface 16 of the annular support 12 and which will serve as support for three movable flaps 18, 20, 22 which will be described later.
- the heart valve 10 is centered about a longitudinal axis X and has a symmetry of revolution about this axis.
- the annular support 12 also has an outer peripheral surface 24 having a peripheral rib 26 intended to receive a suture ring, not shown, for example, made of textile, which enables the surgeon to fix the valve to the cardiac tissues in a known manner by means of stitches. suture.
- valve In Figure 1 the valve is shown in the open position in which the flaps 18, 20 and 22 are in said raised or open position, the flow of blood passing through the valve in the anterograde direction, while in Figure 2, the valve is shown in closed position with the flaps in said lowered or closed position.
- valve may comprise, without this affecting the principle of the invention, only two parts and, in this case, the annular support 12 is of elliptical shape and the oval-shaped flaps, or more than three parts .
- a valve designed to be implanted in the mitral position has, for example, two oval-shaped flaps, but it may also comprise three flaps of another shape.
- the annular support 12 has an upstream edge or leading edge 28 connecting the inner peripheral surface 16 to the outer peripheral surface 24 and which is placed on the upstream side of the anterograde flow.
- the annular support also has a downstream edge or trailing edge 30 which is located on the downstream side of the anterograde flow and which also connects the inner peripheral surface 16 to the outer peripheral surface 24 of the annular support.
- the support 12 also comprises three articular extensions or protuberances 32, 34, 36 which extend from the downstream downstream edge 30, parallel to the longitudinal axis direction X, and which thus form axially extending slots. relative to the peripheral edge 30 and whose base is substantially the same width (dimension perpendicular to the X axis) as the vertex.
- joint extensions 32, 34, 36 in number equal to that of the flaps, are in fact of reduced dimensions compared to the slots equipping cardiac valves of the prior art, as shown schematically in the partial view of FIG. , where it was deliberately superimposed a dotted articular extension noted 2 of a heart valve of the prior art to the joint extension 34 of the valve 10 according to the invention.
- the area of the articular extension 2 projected in the plane of FIG. 3 has been reduced by at least 50%.
- the articular extensions of the valve 10 according to the invention do not comprise any through-opening, unlike the articular extensions of the valves of the prior art, and in particular those exposed in US Pat. No. 6,395,024. That the articular extensions have no through opening improves the behavior of the valve according to the invention vis-à-vis the flow when it is implanted aortic position.
- 6 395 024 has six small openings distributed two by two symmetrically on each of the articular extensions and whose function is to allow the cleaning of the leading edge of the flaps when they are in the open position (raised). Since in the aortic position the blood flow regime is a regime of high pressures, there is a phenomenon of shearing blood flow through these small openings. This results in the creation of six high velocity side jets against the aortic wall and this results in activation of the coagulation phenomenon.
- the flap 18 comprises a central portion 38 to which are connected two lateral wings 40, 42 framing the latter symmetrically and which are inclined relative thereto ( Figures 1 and 7).
- the shutter 18 is symmetrical with respect to a plane passing through the axis Z (axis of symmetry) and which is perpendicular to the plane of FIG. 5.
- the shutter 18 comprises a leading edge 44 which, in the open position of the shutter, as shown in Figures 1, 4a and 4b, is placed on the upstream side of the anterograde flow (arrow A) and, in the closed position, cooperates with the inner peripheral surface 16 of the annular support 12 with specific means arranged on this surface, as will be seen later.
- This leading edge 44 has a convex shape whose curvature oriented downwards (FIGS. 4a, 4b, 5 and 7) is adapted to cooperate with the inner surface 16 of the valve.
- the flap 18 comprises, on the side of the flap opposite the side where the leading edge is located, a trailing edge 46 which is disposed on the downstream side of the antegrade flow.
- the trailing edge 46 comprises two symmetrical portions 46a and 46b which respectively extend from the lateral wings 40 and 42 to a downstream end zone 48 where they meet. join to form a point. This point 48 is aligned along the axis of symmetry Z of the flap.
- the portions 46a and 46b thus give the trailing edge 46 a substantially triangular shape of inverted V whose point coincides with the end zone 48.
- the end zone 48 which is visible in FIG. 7, showing the outer surface 45 of the flap 18 is, for example, raised relative to the outer surface of the flap so as to adopt the substantially "spatulas" shape of an end of the flap. a ski spatula.
- this outer surface has, for example, a generally planar shape in a direction taken by moving from one side wing of the flap to the opposite side wing.
- the substantially spatulated end 48 of the flap forms a point which deviates from the extension of the inner surface 47 of the flap by an angle which is substantially between 2 ° and 4 °.
- the spatulated end 48 of the flap is not parallel to the flow while the flap body is substantially parallel to the direction of the flow.
- each flap reinforces the hydrodynamic mechanism of early closure of the flap accompanying the deceleration of the anterograde flow and which is due to the gradual establishment during this phase of a subtle positive transient pressure gradient. between the outer and inner surfaces of the shutter.
- FIG. 10 illustrates, in a view from above, the flaps 18, 20, 22 of the valve 10 in the closed position, in which the spatulated ends 48 are spaced from each other by a distance of at least 50 microns.
- a central interstice 49 in the form of a star with three branches is thus formed between the respective trailing edges of these flaps.
- This gap prevents any risk of cavitation when closing the shutters and avoids the generation of noise at closing by eliminating the contact between the trailing edges of the flaps at their end zones 48.
- each of the branches extends over a distance corresponding to at least one third of the total length of the trailing edge of the flaps.
- the shutter 18, like all the other shutters, and in particular the shutter 20 in FIGS. 1 to 3 cooperates with the inner peripheral surface 16 of the annular support 12 and, more specifically , with means for guiding the shutter in rotation, as well as with support means which are arranged radially on the inner peripheral surface of the valve.
- the flaps are able to effect a rotational movement between their open position of FIG. 1 and their closed position of FIG. 2.
- the means for guiding the rotation of the flap comprise two profiled recesses 50 and 52 arranged in the thickness of the two respective articular extensions 32 and 36 and which form tracks or arcs for guiding and retaining the lateral wings of the shutter. More particularly, these tracks or arcs cooperate with parts of the trailing edge 46 of the flap which are located at a so-called terminal portion of the side wings 40, 42 ( Figures 3, 4a and 11).
- the valve 10 also comprises several different support means of each flap which are arranged on the inner peripheral surface 16 of the support 12.
- two first lower supporting or supporting means 60, 62 of the flap 18 have a streamlined hydrodynamic shape whose cross section increases in the direction of flow of the anterograde flow.
- the profiled shape ends with an asymmetric hoop-shaped upper end surface 60a, 62a whose slope is more inclined on the opposite side to the articular extensions as shown in FIG. 4b for the support means 62.
- the upper end surface 62a cooperates with a contact zone 44a of the leading edge 44 in order to establish a surface contact between them during the closure of the flap, when said contact zone moves towards the base of the flap. insertion of the support means which is located on the inner peripheral surface 16 of the valve.
- This surface contact makes it possible to distribute the wear due to the contact of the two elements (leading edge of the flap and support means) on a surface instead of having a contact along a nip, as would be the case with the symmetrical profile of the support means 61 shown in dashed lines in Figure 4b.
- the distribution of forces is therefore better distributed thanks to the asymmetrical profile of the head (upper end) of the support means 62 and, more particularly, thanks to the portion 62a1 of the head of the latter which has a radius of curvature large enough to obtain surface contact with the rectilinear contact zone 44a of the leading edge.
- the portion 62a1 has a substantially planar shape, for example, made in the form of a flat, thus conferring on the upper end surface 62a a convex profile on the side of the nearest and substantially flat joint extension on the opposite side .
- the flap 18 In the closed position, the flap 18 then rests with its leading edge 44 (FIG. 4a) on the upper end surfaces 60a, 62a of the means support and, in particular, on the flattened portions of these surfaces.
- two first distinct lower support means of the same type as that described above are also provided on the valve for each other component: the support means 63, 65 for the shutter 20 and the support means 67, 69 for the flap 22, as shown in FIG.
- the valve also comprises second lower support or support means arranged substantially in the median and lower part of each articular extension (FIGS. 4a, 11 and 12) and which are in the form of an element 64, 66, 68 bow-shaped vessel pointing upward, profiled in the direction of anterograde flow.
- Each of the profiled elements 64, 66, 68 of the respective articular extensions 32, 36 and 34 has sufficiently spaced lateral edges (approximately a distance equal to the thickness of the flaps) to serve as support for the lateral edges of the flaps in position. closed.
- first lower support means 60 and 63 and the respective upper support means 70 and 72 of these flaps are offset radially relative to each other in order to avoid that the upper support means are placed in the wake of the first lower support means. This thus makes it possible to avoid the creation, between these lower and upper support means, of micro-disturbances of the flow which would be favorable to the activation of blood platelets.
- This arrangement also ensures that the flap and support surfaces between the first lower support means and the upper support means are sufficiently flushed by the flow during the cardiac cycle.
- the upper end surface of each first lower support means is well exposed to the retrograde current during closure of the flap.
- the upper stops 70 and 71 come into contact with the outer surface of the flap in its upstream portion from the first milliseconds of opening of the valve.
- the volume of the upper support means is substantially increased, thus making the impact surface larger between them. and the outer surface of the flap near its leading edge.
- the concentration of mechanical stresses at the point of contact is reduced, which in the long run avoids possible alterations in the local surface state of the shutter.
- the upper support means must not be too far away from the first lower support means to maintain the effect synchronous and symmetrical opening of the two lateral flaps of the flap and not to increase the volume of the upper bearing means in a proportion that may induce an unnecessary disturbance on the blood flow.
- each upper support means 70, 71 of its first support means closest bottom 60, 62 by a distance which corresponds substantially to at least one dimension (width) of the first lower bearing means which is measured radially.
- the radial dimension or width of the lower support means is approximately 1.5 mm, and the upper support means is thus spaced radially at least 1.5 mm from the wake of the first support means corresponding lower.
- the upper bearing means (abutment) is preferably wider in its upstream part and more tapered in its downstream part since only the upstream part comes into contact with the outer surface of the flap at its opening and which it is important to reduce locally. the stress concentration during the impact.
- the leading edge 44 of the flap 18 is arranged between the first lower support means 60, 62 and the upper support means 70, 71.
- each rotation in rotation defines an axis of rotation (shown in phantom in FIGS. 5 and 7) which extends in a direction taken by moving from one lateral wing of the shutter to the opposite side wing.
- the axis of rotation is located at a distance from the longitudinal axis X of the valve (in a plane perpendicular to this axis) which is greater than 75% of the radius of the annular support 12 of a flap, and this, while allowing blood flow between the outer surface of the flap and the inner peripheral surface 16 of the annular support.
- each axis of rotation is virtual because it is located entirely outside the corresponding flap, between the latter and the annular support.
- the axis is therefore very eccentric with respect to the center of gravity of the shutter.
- the resultant of the frictional forces acting on the flap exerts relative to the virtual axis a movement sufficient to initiate closure of the flap during the deceleration of the blood flow. This promotes the closing movement and makes it much less violent than with some valves of the prior art whose shutters close abruptly, causing both noise and trauma to the blood cells circulating.
- This eccentric arrangement of the axes of rotation of the flaps makes it possible to arrange the flaps, in the open position of the valve, substantially parallel to the axis of the blood flow, or even in a plane substantially exceeding the angle of 90.degree. relative to the plane perpendicular to the X axis, because the only friction forces are sufficient to initiate their closure.
- the presence of the raised end in the shape of a ski spatula of the end zone 48 of each flap contributes to promoting the early closure of the flaps during the deceleration of the flow by using the natural forces of the flow.
- the upper bearing means 70, 71 move away from the first lower support means 60, 62 of the flap 18 and thus increase the leverage sought when the upper edge of the flap lifts due to the pressure exerted on its inner surface at the beginning of the opening phase of the cardiac cycle.
- a very weak hydrodynamic force applied to the inner surface of the closed shutter then causes almost immediately the symmetrical tilting of the flap around its axis of rotation.
- the articular extensions arranged on the downstream edge of the annular support 12 are of considerably reduced dimensions with respect to the joint extensions of the tri-fold valves of the prior art. Therefore, when the flaps are raised (valve in the open position as in Figures 1, 3, 4a, 11 and 12) the outer surface of each side wing of each of the flaps which is arranged in abutment against a part lateral expansion of a corresponding joint extension is considerably reduced compared to the prior art.
- FIG. 11 shows in broken lines the articulation facets 42a and 40a of the lateral wings 42 and 40 of the respective flaps 18 and 20 in contact with the respective extension facets 50a and 52a of the articular extension 32.
- Removal of non-biological surfaces in contact with each other in the flap pivotal space therefore eliminates or at least minimizes the risk of coagulation deposition in this area.
- the invention thus eliminates in practice a vital risk of valvular dysfunction resulting in acute circulatory insufficiency.
- the sum of the fractions of the outer surfaces of the two lateral wings of each flap, that is to say the articulation facets 40a and 42a, which are arranged, in the open position of the shutter, against the respective extension facets 52a and 50a of the corresponding joint extension corresponds to a surface substantially less than 5% to the total outer surface of the flap.
- the surface of the two extension facets is thus, for example, equal to 1, 4% of the total outer surface of the shutter.
- the width of the base of each articular extension can be reduced with respect to the width of its top, so that the extension visible on Figure 3 is more like a mushroom than a niche.
- the lateral flanks of the extension will thus be concave instead of being substantially rectilinear as in FIG.
- FIGS 6 and 8 illustrate a flap 100 of a mechanical prosthetic heart valve trifold according to the prior art, respectively in top view and in perspective.
- the flap 100 comprises two lateral wings 102 and
- connection area is thus similar to the flow at a "ridge" on the outer surface of the flap.
- each lateral flange with the central part of the flap is constant.
- this "edge" on the outer surface of the shutter generates, in the flow, a singularity in the form of a small zone of recirculation downstream, recirculation which is in the immediate vicinity facets of articulation and extension.
- This singularity increases the kinetic energy of the blood cells and in particular the platelets, increases their residence time on the surrounding surfaces and consequently increases the risk of formation of coagulation deposits.
- the lateral flanges 40, 42 of each flap for example the flap 18 shown in FIGS. 5 and 7, each form with the central portion 38 to which they are connected a junction zone 80, 82 of convex outer surface, whose radius of curvature is sufficiently large to prevent the formation of swirling flows in the vicinity of this surface. More particularly, if we consider the length of this junction zone which extends from the leading edge to the trailing edge (parallel to the Z axis), this radius of curvature must be large enough on at least a part of its length including the trailing edge 46 of the shutter.
- the radius of curvature close to the leading edge 44 may be of low value and, over a portion of the length of this junction zone which includes the trailing edge 46, a higher value which makes it possible to avoid the flow to detach from the outer surface of the flap and generate local disturbances.
- a small value of the radius of curvature near the leading edge makes it possible to use lower support means of small size and which thus make little obstruction to the flow.
- the value of the radius of curvature increases in the direction of the anterograde flow along the flap, that is to say towards the trailing edge of the latter.
- FIGS. 5 and 7 An embodiment in accordance with this teaching is, for example, illustrated in FIGS. 5 and 7, wherein the convex outer surface of the junction zone 80, 82 has the general shape of a cone portion whose apex is located towards upstream of the antegrade flow, that is to say the side of the leading edge 44 of the flap, and the opening of the cone is located at the trailing edge.
- the top of the cone may be located more or less near the leading edge in the desired shape.
- the radius of curvature increases, for example, progressively from the leading edge, or near it, towards the trailing edge.
- Figures 13 and 14 respectively illustrate the schematic views taken in the plane of the flap, the leading edge 44 and the trailing edge 46.
- the inner surface of the junction area 80, 82 also has the general shape of a cone portion.
- the value of the radius of curvature at the leading edge for the valves implanted in the aortic position is between 1 and 2 mm and is, for example, equal to 1.15 mm for a valve of outside diameter 19 mm and 1.5 mm. mm for an outer diameter valve 31 mm.
- the value of the radius of curvature at the trailing edge is at least 2 mm, more particularly between 2 and 4 mm and is, for example, equal to 2.5 mm for a diameter of 19 mm and 3.3 mm for a diameter of 31 mm.
- the respective corresponding values of the radii of curvature on the inner surface of the flap are 0.5 and 0.6 mm for the leading edge and 1, 5 and 1, 8 mm for the trailing edge.
- the values of radii of curvature at the leading edge are between 1 and 2 mm and are, for example, equal to 1.32 mm for a valve of external diameter 25 mm and to
- They are at least 2 mm at the trailing edge, more particularly between 2 and 4 mm and are, for example, 2.9 mm for a diameter of 25 mm and 3.3 mm for a diameter of 33 mm. mm.
- the respective corresponding values of the radii of curvature on the inner surface of the flap are 0.52 and 0.6 mm for the leading edge and 1, 6 and 1, 8 mm for the trailing edge.
- the value of the radius of curvature at the leading edge is 50 °, plus or minus 5 °.
- the outer surface 45 of the central part of the shutter 18 is given a shape, for example, substantially convex in a direction taken by moving from the lateral wing 40 at the opposite side wing 42 ( Figure 15) instead of a generally planar shape.
- This convex shape only concerns the zone of the flap close to the leading edge, between the axis of rotation of the flap and the leading edge, the region of the flap located downstream of the axis of rotation is, for its part, rather concave.
- the stroke of the leading edge on the lower lower support means will be substantially shorter, thereby increasing the wear resistance of the valve.
- the convex outer surface of the junction zone between the central part of the flap and each lateral flange adopts the general shape of a cylindrical portion and the radius of curvature is therefore constant.
- the radius of curvature on the outer surface of the flaps is at least 2 mm, more particularly between 2 and 4 mm and, for example, equal to 2.5 mm for a valve of outer diameter equal to 19 mm. It is comprised in 2 and 4 mm and, for example, equal to 3.3 mm for a valve of external diameter equal to 33 mm for valves implanted in the mitral position.
- the arrangement of the cylinder portion junction zone may be useful in some applications where the radius of curvature in the vicinity of the flap leading edge should not be as small as possible.
- each of the articulation facets of each flap for example, the facet 40 a in FIG. 16
- the corresponding extension facet for example, the facet 52a in FIG. 16
- volume of the pivot space is less than
- the valve thus comprises six pivoting spaces 120 in the closed position (FIGS. 2, 10 and 15).
- junction regions 80, 82 of the flaps have the shape of a cone portion or a truncated cone, it is found that the downstream part of these zones (situated on the trailing edge side 46) is lowered relative to at the part of these upstream zones, that is to say at the leading edge 44 (FIGS.
- the zone of joining between the trailing edges of the flaps is lowered, compared with the prior art, with respect to a plane perpendicular to the longitudinal axis X, such that the plane containing the flap leading edge 28 of the annular support 12 (FIG. 17).
- the angle A is therefore reduced thanks to the invention.
- this angle is between 30 and 50 ° and an angle value of 35 ° is particularly suitable for the aortic position.
- an angle of up to 50 ° can be advantageous. It should be noted, however, that a closing angle of 35 ° can be adopted for all sizes of aortic and mitral valves.
- the pivoting space 120 ( Figure 16) becomes more flared and more accessible to retrograde rinsing by the blood stream than in the valves of the prior art where this space is cashed between less flared walls that further impede access for flow.
- pivoting spaces of the rigid three-flap valve are critical spaces for the resistance of the valve to coagulation phenomena.
- the specific arrangement of this space according to the invention aims to reduce as much as possible any stasis on the adjacent walls (flaps and joint extensions), any singularity in the microstructure of the flow at this point and any foreign surface useless to its immediate neighborhood.
- the outer surface 45 of the central portion 38 of each flap is shaped, for example, substantially convex, which increases the central surface of the flaps exposed to the flow antegrade when the valve is in the open position. Coupled with the arrangement of the junction zone with increased radius of curvature between the central part and the lateral flaps of the flaps, this convexity aims to distribute the flow uniformly over the entire outer surface of the flaps and in particular on the lateral facets dedicated to pivoting. This is contrary to what is achieved by the prior art described in US Pat. No. 6,395,024, wherein the shape of the outer surface of the flap tends to move the flow away from the lateral flanges by steering it more readily towards the center of the shutter.
- the main orifice is delimited by the inner surfaces of the shutters.
- the inner surface 47 of the central part of the flaps preferably has in its upstream part a generally concave shape in a direction taken by moving from a lateral flange 40 to the opposite lateral flange 42 (FIG. 15), which positions the upstream portion of each flap including the leading edge in an anterograde blood flow area where the velocities are substantially slower than toward the center of the valve.
- the upstream portion is that located between the leading edge and the axis of rotation of the flap.
- the anterograde flow meeting the leading edge of the flaps is less subject to disturbances than with flaps whose inner surface is of convex shape in the plane of FIG. 15.
- the main orifice is thus substantially widened with respect to the prior art and the passage section offered to the flow by this orifice in a plane perpendicular to the X axis, in particular in the portion of the orifice defined by the upstream portion of the flaps, is at least equal to 75% of the internal surface delimited by the support 12.
- Each secondary orifice 14b, 14c, 14d is, for its part, defined by the space offered to the flow between the outer surface of one of the three flaps and the inner peripheral surface portion of the support 12 which separates the articular extensions with which the relevant part cooperates.
- the secondary orifices each have a general crescent shape.
- each secondary orifice 14b-d is rinsing orifices of the outer surfaces of the flaps and in particular of their lateral wings. It will be noted that the largest passage section offered to flow by each secondary orifice 14b-d in a plane perpendicular to the axis X is less than 7% of the internal surface delimited by the support 12. Moreover, the dimension of each secondary orifice taken in a radial direction passing through the center of the support 12, in a plane perpendicular to the axis X, is less than 20% of the internal radius of the support.
- Figure 18 illustrates the structure of the flow on the flat, even concave outer surface 45 of a shutter in the open position.
- the Applicant has modified the structure of the outer surface of the valves. flaps to promote the orientation of the blood flow to the lateral flaps of the flaps as illustrated in Figure 19.
- the modified outer surface 145 is thus provided with a plurality of grooves 147 shown by way of example in Fig. 20 with a V-shaped cross-section and which are oriented to channel the blood flow in a controlled manner.
- the grooves can be oriented differently according to the areas of the outer surface of the flap where they are arranged: the grooves arranged near the center of the flap are oriented axially along the axis of symmetry Z of the flap, while the grooves arranged near the wings lateral 40, 42 have an axial orientation which forms with the axis Z an angle, for example, between 5 ° and 7.
- This angle can be more pronounced as the grooves are close to the wings. Such an arrangement distributes the flow over a larger surface of the flap and thus promotes the cleaning of the lateral wings. It should be noted that other possible shapes of cross-sections of the grooves are conceivable: U-shaped round shapes, rectangular shapes, trapezoidal shapes, L-shaped fins, etc.
- these grooves have a height h which corresponds substantially to the thickness of the boundary layer of the blood flow on the flap and which is, for example, of the order of 0.01 mm.
- the thickness of the boundary layer can be obtained from the dimensions of a shutter, by applying a scale factor of 1 / (Reynolds number) 1 A
- the distance separating two consecutive grooves is adjusted according to the risk of contamination of the grooves.
- the grooves provided on all or part of the outer surface of the flaps contribute to thicken and stabilize the boundary layer of the flow, thus reducing the turbulent friction and the resulting friction drag generated by the meeting of the flow and the outer surface of the shutters.
- These grooves are obtained in a known manner, for example, by molding when the flaps are made of biocompatible polymers, or by an isotropic diamond deposit a few microns thick if the flaps are made from another material, or by micro-machining.
- the inner surface of the flaps can also be grooved to promote a different flow distribution.
- the peripheral rib 26 provided for fixing a suture ring is for example specifically configured so that its general shape, which can be seen in FIGS. 1 to 3, reproduces the profile of a curve. substantially sinusoidal.
- the vertices of the sinusoidal curve are respectively arranged at the right of each of the articular extensions 32, 34, 36 (top 26a to the right of the extension 34) of the support and the recesses are respectively arranged between two consecutive articular extensions: the recess 26b is arranged between the extensions 34 and 36 while hollow 26c is arranged between extensions 32 and 34.
- the profile of the rib 26 generally follows the contour of the trailing edge 30 of the support 12.
- the rigid flap valve according to the invention, different materials can be used.
- a biocompatible metal such as titanium or stellite.
- the flaps in turn can be made from a biocompatible material, for example monolithic carbon, or graphite with a pyrolytic carbon coating.
- the flaps can also be made in a biocompatible synthetic polymer and which has wear resistance properties comparable to those of pyrolytic carbon.
- a material such as the "Peek" (acronym for
- Polyetheretherketone has a low density of the order of 1, 2 and is particularly suitable for making shutters.
- This material is carbon reinforced to increase the wear resistance of the shutters.
- Such material is provided, for example, by Ensinger
- valve according to the invention can be made of titanium for the annular support 12 and "peek" for the flaps, which provides a pair of materials perfectly suited to the friction and wear encountered on this type of valve.
- the "Peek” as a material for manufacturing the shutters and the pyrolytic carbon for the support, or even the pyrolytic carbon for the shutters and the support.
Abstract
Description
Claims
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0810224A BRPI0810224B8 (pt) | 2007-05-02 | 2008-04-30 | válvula cardíaca protética mecânica |
CN200880023156.4A CN101754729B (zh) | 2007-05-02 | 2008-04-30 | 机械假体心脏瓣膜 |
AU2008263806A AU2008263806B2 (en) | 2007-05-02 | 2008-04-30 | Mechanical prosthetic heart valve |
KR1020097025103A KR101496274B1 (ko) | 2007-05-02 | 2008-04-30 | 기계식 인공 심장 판막 |
MX2009011839A MX2009011839A (es) | 2007-05-02 | 2008-04-30 | Valvula cardiaca protesica mecanica. |
EP08805533.0A EP2142143B1 (fr) | 2007-05-02 | 2008-04-30 | Valve cardiaque prothétique mécanique |
JP2010504794A JP5322013B2 (ja) | 2007-05-02 | 2008-04-30 | 人工心臓弁 |
CA2685802A CA2685802C (fr) | 2007-05-02 | 2008-04-30 | Valve cardiaque prothetique mecanique |
US12/598,516 US10182907B2 (en) | 2007-05-02 | 2008-04-30 | Mechanical prosthetic heart valve |
NZ581537A NZ581537A (en) | 2007-05-02 | 2008-04-30 | Mechanical prosthetic heart valve with flaps contoured for reduced turbulence |
RU2009144546/14A RU2475212C2 (ru) | 2007-05-02 | 2008-04-30 | Механический протез клапана сердца |
IL201881A IL201881A (en) | 2007-05-02 | 2009-11-02 | Mechanical valves heart valve |
IL222517A IL222517A (en) | 2007-05-02 | 2012-10-18 | Mechanical valves heart valve |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0703164A FR2915678B1 (fr) | 2007-05-02 | 2007-05-02 | Valve cardiaque prothetique mecanique |
FR0703164 | 2007-05-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008152224A2 true WO2008152224A2 (fr) | 2008-12-18 |
WO2008152224A3 WO2008152224A3 (fr) | 2009-03-12 |
Family
ID=38951753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2008/000621 WO2008152224A2 (fr) | 2007-05-02 | 2008-04-30 | Valve cardiaque prothétique mécanique |
Country Status (15)
Country | Link |
---|---|
US (1) | US10182907B2 (fr) |
EP (4) | EP2142143B1 (fr) |
JP (1) | JP5322013B2 (fr) |
KR (1) | KR101496274B1 (fr) |
CN (1) | CN101754729B (fr) |
AU (1) | AU2008263806B2 (fr) |
BR (1) | BRPI0810224B8 (fr) |
CA (1) | CA2685802C (fr) |
FR (1) | FR2915678B1 (fr) |
IL (2) | IL201881A (fr) |
MX (1) | MX2009011839A (fr) |
NZ (1) | NZ581537A (fr) |
RU (1) | RU2475212C2 (fr) |
WO (1) | WO2008152224A2 (fr) |
ZA (1) | ZA200907938B (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021144673A1 (fr) | 2020-01-14 | 2021-07-22 | Novostia Sa | Valve cardiaque prothétique mécanique |
WO2021144672A1 (fr) | 2020-01-14 | 2021-07-22 | Novostia Sa | Valvule cardiaque prothétique mécanique |
WO2021144674A1 (fr) | 2020-01-14 | 2021-07-22 | Novostia Sa | Valvule cardiaque prothétique mécanique |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US20060173490A1 (en) * | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
JP6010545B2 (ja) | 2010-12-23 | 2016-10-19 | トゥエルヴ, インコーポレイテッド | 僧帽弁の修復および置換のためのシステム |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
AU2012272855C1 (en) | 2011-06-21 | 2018-04-05 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
AU2012290221B2 (en) * | 2011-07-29 | 2017-02-23 | Carnegie Mellon University | Artificial valved conduits for cardiac reconstructive procedures and methods for their production |
US9763780B2 (en) | 2011-10-19 | 2017-09-19 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US11202704B2 (en) | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
CN107028685B (zh) | 2011-10-19 | 2019-11-15 | 托尔福公司 | 人工心脏瓣膜装置、人工二尖瓣和相关系统及方法 |
AU2012325809B2 (en) | 2011-10-19 | 2016-01-21 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9655722B2 (en) | 2011-10-19 | 2017-05-23 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
EP4049625A1 (fr) * | 2011-12-09 | 2022-08-31 | Edwards Lifesciences Corporation | Valvule cardiaque prothétique ayant des supports de commissures améliorés |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US9427315B2 (en) | 2012-04-19 | 2016-08-30 | Caisson Interventional, LLC | Valve replacement systems and methods |
US9011515B2 (en) | 2012-04-19 | 2015-04-21 | Caisson Interventional, LLC | Heart valve assembly systems and methods |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US9283072B2 (en) | 2012-07-25 | 2016-03-15 | W. L. Gore & Associates, Inc. | Everting transcatheter valve and methods |
US9232995B2 (en) * | 2013-01-08 | 2016-01-12 | Medtronic, Inc. | Valve prosthesis and method for delivery |
ES2603394T3 (es) * | 2012-10-30 | 2017-02-27 | Pierfrancesco VEROUX | Dispositivo endoluminal venoso mejorado para el tratamiento de defectos de las venas |
US10966820B2 (en) | 2012-12-19 | 2021-04-06 | W. L. Gore & Associates, Inc. | Geometric control of bending character in prosthetic heart valve leaflets |
US10039638B2 (en) | 2012-12-19 | 2018-08-07 | W. L. Gore & Associates, Inc. | Geometric prosthetic heart valves |
US9968443B2 (en) * | 2012-12-19 | 2018-05-15 | W. L. Gore & Associates, Inc. | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
US9737398B2 (en) | 2012-12-19 | 2017-08-22 | W. L. Gore & Associates, Inc. | Prosthetic valves, frames and leaflets and methods thereof |
US9144492B2 (en) | 2012-12-19 | 2015-09-29 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves, preformed valve |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
AU2014268631B2 (en) | 2013-05-20 | 2019-08-01 | Twelve, Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
US9421094B2 (en) | 2013-10-23 | 2016-08-23 | Caisson Interventional, LLC | Methods and systems for heart valve therapy |
CN107072783B (zh) * | 2014-05-09 | 2021-03-19 | 福达斯公司 | 替代心脏瓣膜及其使用和制造方法 |
US9974647B2 (en) | 2014-06-12 | 2018-05-22 | Caisson Interventional, LLC | Two stage anchor and mitral valve assembly |
EP3182929B1 (fr) | 2014-08-18 | 2023-08-09 | Edwards Lifesciences Corporation | Cadre avec manchon de suture intégré pour valves prothétiques |
US9827094B2 (en) | 2014-09-15 | 2017-11-28 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
US9750607B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
US9750605B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
US9855141B2 (en) | 2014-12-18 | 2018-01-02 | W. L. Gore & Associates, Inc. | Prosthetic valves with mechanically coupled leaflets |
EP3232989B1 (fr) * | 2014-12-18 | 2020-05-06 | W. L. Gore & Associates, Inc. | Valvules prothétiques à lames valvulaires accouplées mécaniquement |
EP3261583B1 (fr) * | 2015-02-24 | 2019-02-13 | Rijksuniversiteit Groningen | Prothèse de valve cardiaque mécanique pour le ventricule droit |
EP3337428A1 (fr) | 2015-08-21 | 2018-06-27 | Twelve Inc. | Dispositifs de valves cardiaques implantables, dispositifs de réparation de valves mitrales et systèmes et procédés associés |
US10478288B2 (en) | 2015-09-30 | 2019-11-19 | Clover Life Sciences Inc. | Trileaflet mechanical prosthetic heart valve |
WO2017117388A1 (fr) | 2015-12-30 | 2017-07-06 | Caisson Interventional, LLC | Systèmes et méthodes pour thérapie de valvule cardiaque |
WO2017127939A1 (fr) | 2016-01-29 | 2017-08-03 | Neovasc Tiara Inc. | Valvule prothétique permettant d'éviter une obstruction empêchant l'écoulement |
US10265172B2 (en) | 2016-04-29 | 2019-04-23 | Medtronic Vascular, Inc. | Prosthetic heart valve devices with tethered anchors and associated systems and methods |
WO2018071417A1 (fr) | 2016-10-10 | 2018-04-19 | Peca Labs, Inc. | Ensemble valve et endoprothèse transcathéter |
CN113893064A (zh) | 2016-11-21 | 2022-01-07 | 内奥瓦斯克迪亚拉公司 | 用于快速收回经导管心脏瓣膜递送系统的方法和系统 |
US10561495B2 (en) | 2017-01-24 | 2020-02-18 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
US20180256329A1 (en) * | 2017-03-07 | 2018-09-13 | 4C Medical Technologies, Inc. | Systems, methods and devices for prosthetic heart valve with single valve leaflet |
US10702378B2 (en) | 2017-04-18 | 2020-07-07 | Twelve, Inc. | Prosthetic heart valve device and associated systems and methods |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US10433961B2 (en) | 2017-04-18 | 2019-10-08 | Twelve, Inc. | Delivery systems with tethers for prosthetic heart valve devices and associated methods |
US10792151B2 (en) | 2017-05-11 | 2020-10-06 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
US10646338B2 (en) | 2017-06-02 | 2020-05-12 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US10709591B2 (en) | 2017-06-06 | 2020-07-14 | Twelve, Inc. | Crimping device and method for loading stents and prosthetic heart valves |
US10786352B2 (en) | 2017-07-06 | 2020-09-29 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10729541B2 (en) | 2017-07-06 | 2020-08-04 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
EP3672530A4 (fr) | 2017-08-25 | 2021-04-14 | Neovasc Tiara Inc. | Prothèse de valvule mitrale transcathéter à déploiement séquentiel |
WO2019055577A1 (fr) | 2017-09-12 | 2019-03-21 | W. L. Gore & Associates, Inc. | Fixation de cadre de feuillet pour valves prothétiques |
EP3687451B1 (fr) | 2017-09-27 | 2023-12-13 | Edwards Lifesciences Corporation | Valvule prothétique à cadre extensible |
AU2018342223B2 (en) | 2017-09-27 | 2021-04-01 | Edwards Lifesciences Corporation | Prosthetic valves with mechanically coupled leaflets |
EP3694445A1 (fr) | 2017-10-13 | 2020-08-19 | W. L. Gore & Associates, Inc. | Valvule prothétique télescopique et système de pose |
CN114831777A (zh) | 2017-10-31 | 2022-08-02 | W.L.戈尔及同仁股份有限公司 | 假体心脏瓣膜 |
CN111295158A (zh) | 2017-10-31 | 2020-06-16 | W.L.戈尔及同仁股份有限公司 | 医用瓣膜和促进组织向内生长的瓣叶 |
CA3178262A1 (fr) | 2017-10-31 | 2019-05-09 | W. L. Gore & Associates, Inc. | Systemes de deploiement par transcatheter et procedes associes |
US11154397B2 (en) | 2017-10-31 | 2021-10-26 | W. L. Gore & Associates, Inc. | Jacket for surgical heart valve |
CN108030572B (zh) * | 2017-11-29 | 2019-07-19 | 天津大学 | 一种瓣膜式防返流胆道支架 |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
USD926322S1 (en) | 2018-11-07 | 2021-07-27 | W. L. Gore & Associates, Inc. | Heart valve cover |
US11737872B2 (en) | 2018-11-08 | 2023-08-29 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
JP7438236B2 (ja) | 2019-04-01 | 2024-02-26 | ニオバスク ティアラ インコーポレイテッド | 制御可能に展開可能な補綴弁 |
EP3952792A4 (fr) | 2019-04-10 | 2023-01-04 | Neovasc Tiara Inc. | Valvule prothétique à circulation sanguine naturelle |
US11779742B2 (en) | 2019-05-20 | 2023-10-10 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
AU2020295566B2 (en) | 2019-06-20 | 2023-07-20 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
CN114081676A (zh) * | 2021-11-18 | 2022-02-25 | 山东大学 | 一种心脏瓣膜模拟装置、制造模具及工艺 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5522886A (en) | 1994-07-29 | 1996-06-04 | Milo; Simcha | Heart valve prostheses |
US6059826A (en) | 1997-05-13 | 2000-05-09 | Medical Carbon Research Institute, Llc | Trileaflet heart valve |
US6395024B1 (en) | 1997-05-20 | 2002-05-28 | Triflo Medical, Inc. | Mechanical heart valve |
US20040249451A1 (en) | 2003-06-06 | 2004-12-09 | Po-Chien Lu | Tri-leaflet mechanical heart valve |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4328592A (en) * | 1979-08-07 | 1982-05-11 | Hemex, Inc. | Heart valve prosthesis |
FR2642960B1 (fr) | 1989-02-15 | 1994-02-25 | Dassault Breguet Aviation | Valve cardiaque prothetique |
JP3032600B2 (ja) | 1991-02-21 | 2000-04-17 | 株式会社リコー | 光情報記録媒体 |
US5192309A (en) * | 1991-03-25 | 1993-03-09 | Onx, Inc. | Prosthetic heart valve |
WO1992021305A1 (fr) * | 1991-06-06 | 1992-12-10 | Medtronic, Inc. | Prothese de valvule cardiaque a deux valves a courbure composite |
RU2093109C1 (ru) * | 1995-01-27 | 1997-10-20 | Акционерное общество открытого типа "Кирово-Чепецкий химический комбинат им.Б.П.Константинова" | Протез клапана сердца |
RU2104676C1 (ru) * | 1995-04-12 | 1998-02-20 | Научно-производственное предприятие "Акционерное общество МедИнж" | Протез клапана сердца |
US5545216A (en) | 1995-05-16 | 1996-08-13 | Medical Carbon Research Institute, Llc | Prosthetic heart valve |
US5772694A (en) | 1995-05-16 | 1998-06-30 | Medical Carbon Research Institute L.L.C. | Prosthetic heart valve with improved blood flow |
CA2218621C (fr) | 1995-05-16 | 2006-10-24 | Medical Carbon Research Institute, L.L.C. | Valvule cardiaque prothetique |
US5641324A (en) | 1995-05-16 | 1997-06-24 | Medical Carbon Research Institute, Llc | Prosthetic heart valve |
RU2113191C1 (ru) | 1996-02-14 | 1998-06-20 | Александр Петрович Мельников | Протез клапана сердца |
US5861029A (en) | 1996-02-14 | 1999-01-19 | Evdokimov; Sergey V. | Heart valve prosthesis |
US5628791A (en) | 1996-05-09 | 1997-05-13 | Medical Carbon Research Institute, Llc | Prosthetic trileaflet heart valve |
DE19624951A1 (de) | 1996-06-24 | 1998-01-02 | Adiam Medizintechnik Gmbh & Co | Prothetische Herzklappe |
CA2257205C (fr) | 1996-06-24 | 2005-11-22 | Adiam Medizintechnik Gmbh & Co. Kg | Valvule cardiaque prothetique |
US5814099A (en) | 1996-08-12 | 1998-09-29 | Bicer; Demetrio | Central opening curved bileaflet heart valve prosthesis |
US6764509B2 (en) | 1996-09-06 | 2004-07-20 | Carbomedics Inc. | Prosthetic heart valve with surface modification |
US6702851B1 (en) | 1996-09-06 | 2004-03-09 | Joseph A. Chinn | Prosthetic heart valve with surface modification |
US6068657A (en) * | 1997-05-20 | 2000-05-30 | Lapeyre; Didier | Mechanical valve prosthesis with optimized closing mode |
US5919226A (en) | 1997-07-22 | 1999-07-06 | Medtronic, Inc. | Mechanical heart valve prosthesis |
TW329667U (en) * | 1997-08-04 | 1998-04-11 | Nat Science Council | Trifoliate artificial heart valve |
US5908451A (en) | 1997-11-25 | 1999-06-01 | Cardiotech International Corporation | Prosthetic heart valve |
JP4080690B2 (ja) | 1997-12-05 | 2008-04-23 | セント ジュード メディカル インコーポレイテッド | 二葉弁式人工心臓弁 |
US6096075A (en) | 1998-01-22 | 2000-08-01 | Medical Carbon Research Institute, Llc | Prosthetic heart valve |
RU2157674C1 (ru) | 1999-07-27 | 2000-10-20 | Иофис Наум Абрамович | Искусственный клапан сердца |
RU2146906C1 (ru) | 1998-12-28 | 2000-03-27 | Иофис Наум Абрамович | Протез клапана сердца |
WO2000038595A1 (fr) | 1998-12-28 | 2000-07-06 | Alexandr Vasilievich Samkov | Prothese de valvule du coeur |
US6051022A (en) | 1998-12-30 | 2000-04-18 | St. Jude Medical, Inc. | Bileaflet valve having non-parallel pivot axes |
US6395025B1 (en) | 1998-12-31 | 2002-05-28 | St. Jude Medical, Inc. | Mechanical heart valve prosthesis |
US6200340B1 (en) | 1999-04-01 | 2001-03-13 | Sulzer Carbomedics Inc. | Tilting disk heart valve having cavitation reducing contact geometry |
US6139575A (en) | 1999-04-02 | 2000-10-31 | Medtronic, Inc. | Hybrid mechanical heart valve prosthesis |
WO2001034068A1 (fr) | 1999-11-10 | 2001-05-17 | Impsa International Incorporated | Prothese valvulaire cardiaque |
CA2407200C (fr) | 2000-05-03 | 2007-01-23 | Shlomo Gabbay | Procede et systeme permettant d'obtenir une prothese de valvule cardiaque biologiquement recouverte |
CA2412063C (fr) | 2000-05-03 | 2006-10-17 | Shlomo Gabbay | Prothese de valvule cardiaque biomecanique et methode de fabrication |
US6610088B1 (en) | 2000-05-03 | 2003-08-26 | Shlomo Gabbay | Biologically covered heart valve prosthesis |
WO2002024119A1 (fr) | 2000-09-21 | 2002-03-28 | St. Jude Medical, Inc. | Protheses a valves comportant des valves polymeres renforcees |
US6596024B2 (en) | 2000-12-21 | 2003-07-22 | Carbomedics Inc. | Polymeric heart valve fabricated from polyurethane/polysiliconeurethane blends |
GB2371988B (en) | 2001-02-08 | 2002-12-24 | Tayside Flow Technologies Ltd | Valve |
US20030069635A1 (en) | 2001-05-29 | 2003-04-10 | Cartledge Richard G. | Prosthetic heart valve |
US6951573B1 (en) | 2001-12-22 | 2005-10-04 | Dilling Emery W | Prosthetic aortic valve |
US20030135270A1 (en) | 2002-01-17 | 2003-07-17 | Breznock Eugene M. | Polyurethane sufrace buttressed cardiac valve suture ring |
AU2003268220B8 (en) | 2002-08-28 | 2010-01-21 | Hlt, Inc. | Method and device for treating diseased valve |
US20040122515A1 (en) | 2002-11-21 | 2004-06-24 | Xi Chu | Prosthetic valves and methods of manufacturing |
US20050021134A1 (en) | 2003-06-30 | 2005-01-27 | Opie John C. | Method of rendering a mechanical heart valve non-thrombogenic with an electrical device |
DE10340265A1 (de) | 2003-08-29 | 2005-04-07 | Sievers, Hans-Hinrich, Prof. Dr.med. | Prothese zum Ersatz der Aorten- und/oder Mitralklappe des Herzens |
US20050075725A1 (en) * | 2003-10-02 | 2005-04-07 | Rowe Stanton J. | Implantable prosthetic valve with non-laminar flow |
US7261732B2 (en) | 2003-12-22 | 2007-08-28 | Henri Justino | Stent mounted valve |
JP4494421B2 (ja) | 2004-01-22 | 2010-06-30 | アドヴァンスト サージカル デザイン アンド マニュファクチャー リミテッド | 心臓弁 |
US7871435B2 (en) | 2004-01-23 | 2011-01-18 | Edwards Lifesciences Corporation | Anatomically approximate prosthetic mitral heart valve |
US7247167B2 (en) | 2004-02-19 | 2007-07-24 | Shlomo Gabbay | Low profile heart valve prosthesis |
CN102028565B (zh) | 2005-07-13 | 2012-07-18 | 爱德华兹生命科学公司 | 具有带周线的缝合环的修复性二尖瓣心脏瓣膜 |
US7776084B2 (en) | 2005-07-13 | 2010-08-17 | Edwards Lifesciences Corporation | Prosthetic mitral heart valve having a contoured sewing ring |
WO2007016097A2 (fr) | 2005-07-27 | 2007-02-08 | Georgia Tech Research Corporation | Valvule veineuse prothétique implantable |
US20070038295A1 (en) | 2005-08-12 | 2007-02-15 | Cook Incorporated | Artificial valve prosthesis having a ring frame |
RU2302220C1 (ru) | 2005-12-23 | 2007-07-10 | Александр Петрович Мельников | Протез клапана сердца |
RU2325874C2 (ru) | 2006-04-04 | 2008-06-10 | Александр Васильевич Самков | Протез клапана сердца |
US9554901B2 (en) | 2010-05-12 | 2017-01-31 | Edwards Lifesciences Corporation | Low gradient prosthetic heart valve |
US20140074228A1 (en) | 2012-09-04 | 2014-03-13 | Justin Negri | Prosthetic heart valve |
-
2007
- 2007-05-02 FR FR0703164A patent/FR2915678B1/fr active Active
-
2008
- 2008-04-30 EP EP08805533.0A patent/EP2142143B1/fr active Active
- 2008-04-30 EP EP13167103.4A patent/EP2626040B1/fr active Active
- 2008-04-30 EP EP10012015.3A patent/EP2292186B1/fr active Active
- 2008-04-30 NZ NZ581537A patent/NZ581537A/xx unknown
- 2008-04-30 AU AU2008263806A patent/AU2008263806B2/en active Active
- 2008-04-30 MX MX2009011839A patent/MX2009011839A/es not_active Application Discontinuation
- 2008-04-30 RU RU2009144546/14A patent/RU2475212C2/ru active
- 2008-04-30 CN CN200880023156.4A patent/CN101754729B/zh active Active
- 2008-04-30 US US12/598,516 patent/US10182907B2/en active Active
- 2008-04-30 JP JP2010504794A patent/JP5322013B2/ja active Active
- 2008-04-30 CA CA2685802A patent/CA2685802C/fr active Active
- 2008-04-30 BR BRPI0810224A patent/BRPI0810224B8/pt active IP Right Grant
- 2008-04-30 EP EP13167113.3A patent/EP2626041B1/fr active Active
- 2008-04-30 WO PCT/FR2008/000621 patent/WO2008152224A2/fr active Application Filing
- 2008-04-30 KR KR1020097025103A patent/KR101496274B1/ko active IP Right Grant
-
2009
- 2009-11-02 IL IL201881A patent/IL201881A/en active IP Right Grant
- 2009-11-11 ZA ZA200907938A patent/ZA200907938B/xx unknown
-
2012
- 2012-10-18 IL IL222517A patent/IL222517A/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5522886A (en) | 1994-07-29 | 1996-06-04 | Milo; Simcha | Heart valve prostheses |
US6059826A (en) | 1997-05-13 | 2000-05-09 | Medical Carbon Research Institute, Llc | Trileaflet heart valve |
US6395024B1 (en) | 1997-05-20 | 2002-05-28 | Triflo Medical, Inc. | Mechanical heart valve |
US20040249451A1 (en) | 2003-06-06 | 2004-12-09 | Po-Chien Lu | Tri-leaflet mechanical heart valve |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021144673A1 (fr) | 2020-01-14 | 2021-07-22 | Novostia Sa | Valve cardiaque prothétique mécanique |
WO2021144672A1 (fr) | 2020-01-14 | 2021-07-22 | Novostia Sa | Valvule cardiaque prothétique mécanique |
WO2021144674A1 (fr) | 2020-01-14 | 2021-07-22 | Novostia Sa | Valvule cardiaque prothétique mécanique |
US11607312B2 (en) | 2020-01-14 | 2023-03-21 | Novostia Sa | Mechanical prosthetic heart valve |
US11751992B2 (en) | 2020-01-14 | 2023-09-12 | Novostia Sa | Mechanical prosthetic heart valve |
US11826247B2 (en) | 2020-01-14 | 2023-11-28 | Novostia Sa | Mechanical prosthetic heart valve |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2292186B1 (fr) | Valve cardiaque prothétique mécanique | |
EP0220097B1 (fr) | Valve cardiaque prothétique | |
AU733842B2 (en) | Trileaflet heart valve | |
US5628791A (en) | Prosthetic trileaflet heart valve | |
EP0465383B1 (fr) | Valve cardiaque artificielle | |
EP0383676A1 (fr) | Valve cardiaque prothétique | |
EP0079844B1 (fr) | Prothèse valvulaire cardiaque | |
CH717037A1 (fr) | Valve cardiaque prothétique mécanique. | |
CH717036A1 (fr) | Valve cardiaque prothétique mécanique. | |
WO2011055079A1 (fr) | Filtre pour veine cave et kits le renfermant | |
AU2013200056B2 (en) | Mechanical prosthetic heart valve | |
WO2009092907A2 (fr) | Prothese de disques intervertebraux | |
CH717035A1 (fr) | Valve cardiaque prothétique mécanique. | |
JPH1156882A (ja) | 人工心臓弁装置 | |
FR2758079A1 (fr) | Implant intra-corneen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880023156.4 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08805533 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008805533 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010504794 Country of ref document: JP Ref document number: 2685802 Country of ref document: CA Ref document number: MX/A/2009/011839 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12598516 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3882/KOLNP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008263806 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 581537 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 20097025103 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009144546 Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: 2008263806 Country of ref document: AU Date of ref document: 20080430 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0810224 Country of ref document: BR Kind code of ref document: A2 Effective date: 20091030 |